Science 37 (NASDAQ:SNCE) Trading Down 6.4%

Science 37 Holdings Inc (NASDAQ:SNCE) shares dropped 6.4% during trading on Thursday . The company traded as low as $9.00 and last traded at $9.00. Approximately 2,281 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 267,457 shares. The stock had previously closed at $9.62.

SNCE has been the subject of a number of analyst reports. Cowen assumed coverage on shares of Science 37 in a research report on Friday, October 22nd. They issued an “outperform” rating and a $14.00 price objective for the company. William Blair initiated coverage on shares of Science 37 in a research report on Monday, November 1st. They issued an “outperform” rating for the company. Robert W. Baird initiated coverage on shares of Science 37 in a report on Monday, November 1st. They set an “outperform” rating and a $15.00 target price on the stock. Finally, Lake Street Capital boosted their target price on shares of Science 37 from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Tuesday, November 16th.

The firm’s 50 day simple moving average is $11.54.

Science 37 (NASDAQ:SNCE) last posted its quarterly earnings data on Monday, November 15th. The company reported ($3.28) EPS for the quarter, beating the Zacks’ consensus estimate of ($5.54) by $2.26. The firm had revenue of $14.24 million during the quarter.

Science 37 Company Profile (NASDAQ:SNCE)

Science 37 Inc provides operating system for agile clinical trials. Science 37 Inc, formerly known as LifeSci Acquisition II Corp., is based in LOS ANGELES.

Featured Article: Stock Split

Receive News & Ratings for Science 37 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science 37 and related companies with MarketBeat.com's FREE daily email newsletter.